Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Erlotinib 150 / Bevacizumab 15, Non-Small Cell (Adeno) Lung Carcinoma

Protocol-ID: 742 V1.0 (Mini), ERLO150/BEVA15, NSCLC (Adeno)

Indication(s)

  • Lung Carcinoma, Non-Small Cell (non-squamous, EGFR activating mutation); ICD-10 C34.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 29.07.2016